Gnb2-flox Mouse
一般名
Gnb2-flox
製品ID
S-CKO-17477
背景情報
C57BL/6JCya
系統ID
CKOCMP-14693-Gnb2-B6J-VB
状況
このマウス系統を論文で使用する場合は、「Gnb2-flox Mouse(カタログ番号S-CKO-17477)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Gnb2-flox
系統ID
CKOCMP-14693-Gnb2-B6J-VB
遺伝子名
製品ID
S-CKO-17477
遺伝子別名
Gnb-2, Hg2c1
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 5
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000031726
NCBIトランスクリプトID
NM_010312
ターゲット領域
Exon 2~10
有効領域の大きさ
~3.3 kb
遺伝子研究の概要
Gnb2, or Guanine-nucleotide binding protein 2, encodes for the β2 subunit (Gβ2) of the G-protein complex. G-proteins mediate signalling pathways involved in diverse cellular functions [2,3,5,9]. The G-protein complex, consisting of Gα and Gβγ units, is integral in integrating signals between receptors and effector proteins [3,9].
Mutations in Gnb2 have been associated with several diseases. In Sturge-Weber syndrome (SWS), a rare neurovascular disorder, a somatic mutation in Gnb2 was found in one patient negative for the common GNAQ mutation. This mutation in Gnb2, like the GNAQ mutation, may lead to failure of G-protein complex reassembly, dysregulated MAPK signalling, and reduced synthesis of Yes-associated protein (YAP), suggesting a role of the Hippo signalling pathway in SWS vascular pathogenesis [1,8]. In addition, de novo missense variants in Gnb2 can cause syndromic intellectual disability with variable dysmorphism and extraneurologic features [3,5,9]. A heterozygous mutation in Gnb2 clinically leads to sinus bradycardia and sinus node dysfunction [6].
In cancer, Gnb2 is notably up-regulated in twenty-three cancer types relative to controls, and its elevated expression is associated with reduced overall survival in Liver Hepatocellular Carcinoma and Rectum Adenocarcinoma, suggesting it plays a role in the tumorigenesis of these cancers [2]. Also, in breast cancer, miR-142-3p can improve paclitaxel sensitivity by targeting Gnb2 and inhibiting autophagy through the GNB2-AKT-mTOR pathway [7]. In colorectal cancer, lncRNA CCAT2 promotes cancer cell proliferation and metastasis by regulating GNB2 expression and activating the ERK and Wnt signalling pathways [10]. Lidocaine-induced apoptosis in rat pheochromocytoma PC12 cells is mediated by Gnb2 [4].
In conclusion, Gnb2 is crucial for the normal function of G-protein-mediated signalling pathways. Its mutations and dysregulation are associated with various diseases including SWS, neurodevelopmental disorders, sinus node dysfunction, and multiple cancers. Understanding Gnb2's role through these disease associations helps in elucidating disease mechanisms and may potentially guide future therapeutic strategies.
References:
1. Yeom, SangEun, Comi, Anne M. 2022. Updates on Sturge-Weber Syndrome. In Stroke, 53, 3769-3779. doi:10.1161/STROKEAHA.122.038585. https://pubmed.ncbi.nlm.nih.gov/36263782/
2. Zhang, L, Sahar, A M, Li, C, Feng, W, Hameed, Y. 2022. A detailed multi-omics analysis of GNB2 gene in human cancers. In Brazilian journal of biology = Revista brasleira de biologia, 84, e260169. doi:10.1590/1519-6984.260169. https://pubmed.ncbi.nlm.nih.gov/35730811/
3. Tan, Natalie B, Pagnamenta, Alistair T, Ferla, Matteo P, Christodoulou, John, White, Susan M. 2021. Recurrent de novo missense variants in GNB2 can cause syndromic intellectual disability. In Journal of medical genetics, 59, 511-516. doi:10.1136/jmedgenet-2020-107462. https://pubmed.ncbi.nlm.nih.gov/34183358/
4. Tan, Yonghong, Wang, Qiong, Zhao, Baisong, She, Yingjun, Bi, Xiaobao. 2016. GNB2 is a mediator of lidocaine-induced apoptosis in rat pheochromocytoma PC12 cells. In Neurotoxicology, 54, 53-64. doi:10.1016/j.neuro.2016.03.015. https://pubmed.ncbi.nlm.nih.gov/27018092/
5. Lansdon, Lisa A, Fleming, Emily A, Viso, Florencia Del, Sullivan, Bonnie R, Saunders, Carol J. 2021. Second patient with GNB2-related neurodevelopmental disease: Further evidence for a gene-disease association. In European journal of medical genetics, 64, 104243. doi:10.1016/j.ejmg.2021.104243. https://pubmed.ncbi.nlm.nih.gov/33971351/
6. Kayser, Anne, Dittmann, Sven, Hamidi, Jassin, Hansen, Arne, Schulze-Bahr, Eric. 2024. Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A). In Stem cell research, 78, 103446. doi:10.1016/j.scr.2024.103446. https://pubmed.ncbi.nlm.nih.gov/38776645/
7. Shi, Yingxiang, Wang, Jing, Tao, Shuang, Shi, Yurong, Yang, Qingling. 2022. miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway. In Cellular signalling, 103, 110566. doi:10.1016/j.cellsig.2022.110566. https://pubmed.ncbi.nlm.nih.gov/36539001/
8. Fjær, Roar, Marciniak, Katarzyna, Sundnes, Olav, Haraldsen, Guttorm, Selmer, Kaja Kristine. . A novel somatic mutation in GNB2 provides new insights to the pathogenesis of Sturge-Weber syndrome. In Human molecular genetics, 30, 1919-1931. doi:10.1093/hmg/ddab144. https://pubmed.ncbi.nlm.nih.gov/34124757/
9. Fukuda, Tokiko, Hiraide, Takuya, Yamoto, Kaori, Ogata, Tsutomu, Saitsu, Hirotomo. 2019. Exome reports A de novo GNB2 variant associated with global developmental delay, intellectual disability, and dysmorphic features. In European journal of medical genetics, 63, 103804. doi:10.1016/j.ejmg.2019.103804. https://pubmed.ncbi.nlm.nih.gov/31698099/
10. Tian, Jinhai, Cao, Xu, Jiang, Zongying, Zhao, Sien, Sun, Jianmin. . LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression. In Cancer medicine, 13, e70169. doi:10.1002/cam4.70169. https://pubmed.ncbi.nlm.nih.gov/39225546/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
